Newsroom | 42996 results

BOSTON--(BUSINESS WIRE)--Atrandi Biosciences announced it will present new scientific data and platform innovations at the SLAS2026 International Conference and Exhibition...

BOSTON--(BUSINESS WIRE)--EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, in collaboration with President Trump’s administration, announced new patient access pathways to make its complete portfolio of infertility medications used for in vitro fertilization (IVF), including Gonal-f® (follitropin alfa for injection), Ovidrel® (choriogonadotropin alfa injection), and Cetrotide® (cetrorelix acetate for injection), more accessible to prescribed infertili...

HOUSTON--(BUSINESS WIRE)--The American Dental Association Foundation (ADAF) is officially kicking off Give Kids A Smile® (GKAS) 2026 at UTHealth Houston School of Dentistry, marking 24 years of transforming children’s lives through this access-to-oral-health-care initiative. What began as a local grassroots movement in St. Louis, MO, has evolved into a national movement, having served more than 10.2 million underserved children since 2003. GKAS begins nationally in February, which is National C...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of EDEN, a large, multi-center prospective study designed to evaluate the company’s non-invasive prenatal screening test for early risk assessment of preeclampsia and other serious pregnancy complications. Preeclampsia affects approximately 5-8% of pregnancies and remains a leading cause of maternal and neonatal morbidity.1 While clinical guidelines re...

LONDON--(BUSINESS WIRE)--Real Chemistry, ein weltweit führendes Unternehmen im Bereich KI- und erkenntnisgestützte Gesundheitskommunikation, gab heute ein Update zu seiner globalen Wachstumsstrategie bekannt, das die Ernennung von vier internationalen Führungskräften und die Erweiterung seiner regionalen Präsenz beinhaltet. Diese Neuerungen spiegeln das anhaltende Bestreben von Real Chemistry wider, Kunden und Marken aus dem Gesundheitswesen, die sich in einem zunehmend komplexen, marktübergrei...

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported fourth quarter 2025 GAAP loss per diluted share of $3.15 and adjusted loss per diluted share of $2.75. The Company also reported full year 2025 GAAP earnings per diluted share of $8.92 and adjusted earnings per diluted share of $11.03. Financial results are summarized below:   Three months ended   Year ended   December 31,   December 31,   2025   2024   2025   2024                 (In million...

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EST on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 105...

ORMAND BEACH, Fla.--(BUSINESS WIRE)--Elite Learning, a comprehensive online learning destination for licensed professionals, today announced the release of The Nurse’s Casebook, a scenario-based guide featuring malpractice cases to help protect nursing professionals and their patients. “Every healthcare professional has experienced it: that patient case that sticks with you long after your shift ends. Whether bizarre, mysterious, or tragic, those are the cases that challenge our knowledge, test...

OAK RIDGE, Tenn.--(BUSINESS WIRE)--The U.S. Department of Energy (DOE) National Supplemental Screening Program (NSSP), managed by ORAU, is celebrating 20 years of continued service and encourages those eligible to participate in the program. The NSSP, part of the DOE Former Worker Medical Screening Program (FWP), offers medical screening exams at no cost to DOE former federal, contractor and subcontractor workers who may be at risk for occupational diseases. To date, more than 25,000 individual...

SAN FRANCISCO--(BUSINESS WIRE)--As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year, the event continued to distinguish itself as a leading hub for early-stage biotechnology companies seeking meaningful visibility, strategic dialogue, and access to private investment. Held alongside the J.P. Morgan Healthcare Conference, Biotech Showcase facilitated 6,000 partnering and investment meetings, complemented by more than 250 company presentations and 23 sessions that delivered f...